|Send to printer »|
GEN Exclusives: January 06, 2012
Biopharma IPO Forecast for 2012 Expected to Remain Chilly
In a survey of venture capitalists and CEOs, 58% predict reduced investment.
To enjoy more articles like this from GEN, click here to subscribe now!
© 2018 Genetic Engineering & Biotechnology News, All Rights Reserved